Alkermes Plc (ALKS)
45.97
-0.14
(-0.30%)
USD |
NASDAQ |
Sep 11, 16:00
45.98
+0.01
(+0.02%)
After-Hours: 20:00
Alkermes Market Cap : 7.702B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 7.702B |
| September 10, 2026 | 7.725B |
| September 09, 2026 | 7.606B |
| September 08, 2026 | 7.621B |
| September 04, 2026 | 7.724B |
| September 03, 2026 | 7.854B |
| September 02, 2026 | 7.995B |
| September 01, 2026 | 7.908B |
| August 31, 2026 | 7.873B |
| August 28, 2026 | 7.943B |
| August 27, 2026 | 8.193B |
| August 26, 2026 | 8.236B |
| August 25, 2026 | 8.245B |
| August 24, 2026 | 8.188B |
| August 21, 2026 | 8.097B |
| August 20, 2026 | 8.045B |
| August 19, 2026 | 8.407B |
| August 18, 2026 | 8.290B |
| August 17, 2026 | 8.352B |
| August 14, 2026 | 8.220B |
| August 13, 2026 | 8.285B |
| August 12, 2026 | 8.424B |
| August 11, 2026 | 8.245B |
| August 10, 2026 | 8.277B |
| August 07, 2026 | 8.238B |
| Date | Value |
|---|---|
| August 06, 2026 | 8.104B |
| August 05, 2026 | 8.312B |
| August 04, 2026 | 8.322B |
| August 03, 2026 | 8.298B |
| July 31, 2026 | 8.208B |
| July 30, 2026 | 8.382B |
| July 29, 2026 | 8.099B |
| July 28, 2026 | 8.461B |
| July 27, 2026 | 8.834B |
| July 24, 2026 | 8.861B |
| July 23, 2026 | 8.875B |
| July 22, 2026 | 8.753B |
| July 21, 2026 | 8.798B |
| July 20, 2026 | 8.609B |
| July 17, 2026 | 8.776B |
| July 16, 2026 | 8.646B |
| July 15, 2026 | 8.653B |
| July 14, 2026 | 8.589B |
| July 13, 2026 | 8.634B |
| July 10, 2026 | 8.646B |
| July 09, 2026 | 8.952B |
| July 08, 2026 | 9.037B |
| July 07, 2026 | 9.192B |
| July 06, 2026 | 9.179B |
| July 02, 2026 | 9.086B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 289.83M |
| Jazz Pharmaceuticals Plc | 15.93B |
| Prothena Corp. Plc | 462.08M |
| Biogen, Inc. | 32.07B |
| Cytokinetics, Inc. | 10.24B |
Market Cap Related Metrics
| PE Ratio | 119.40 |
| PS Ratio | 4.670 |
| Price to Book Value | 4.259 |
| Price to Free Cash Flow | 35.14 |
| Price | 45.97 |
| Earnings Yield | 0.84% |
| Operating PE Ratio | 54.21 |
| Normalized PE Ratio | 93.51 |